A Novel Effective Treatment for Erectile Dysfunction in Severe ED Patients Who Respond Poorly to PDE5 Inhibitor Therapy.
BY: Ilan Gruenwald, MD, Boaz Appel, MD, and Yoram Vardi, MD
Neuro-urology Unit, Rambam Healthcare Campus, Haifa, Israel
Erectile dysfunction (ED) is one of the most common disorders of middle-aged men that profoundly affect their quality of life . Although tremendous advances for treating this disorder have been made in the past decade, most currently available treatment modalities still rely on an “on demand” regime, of which up to 35% are unsuccessful [2–4]. From our experience, ED patients who were treated with a phosphodiesterase type 5 inhibitor (PDE5i) tend to search for an alternative treatment modality that would ameliorate their ED. Hence, there is a need for an effective new treatment concept that would have a durable effect on the spontaneous improvement of erectile function. Read More